OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator.

2023-12-31-accounts

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

Registered number: 03502244 Charity number: 1068673

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT AND FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

CONTENTS

Page
Reference and Administrative Details of the Federation, its Trustees and persons co- 1
opted to the board and Advisers
Trustees' Report 2 - 15
Independent Auditors' Report on the Financial Statements 16 - 20
Statement of Financial Activities 21
Balance Sheet 22
Statement of Cash Flows 23
Notes to the Financial Statements 24 - 44

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

REFERENCE AND ADMINISTRATIVE DETAILS OF THE FEDERATION, ITS TRUSTEES AND PERSONS CO-OPTED TO THE BOARD AND ADVISERS FOR THE YEAR ENDED 31 DECEMBER 2023

Trustees and persons co- Prof. Wolfgang Grisold, (Austria) President opted to the board Prof. Guy Rouleau, (Canada) Vice President Prof. Steven Lewis M.D., (USA) Secretary General Prof. Morris Freedman, (Canada) Treasurer Prof. Alla Guekht, (Russia) Prof. Chandrashakhar Meshram, (India) Prof. Mohammad Wasay, (Pakistan) (appointed 15 October 2023) Prof. Minerva Lopez Ruiz, (Mexico) (appointed 17 November 2023) Prof. Maria Benabdeljlil, (Morocco) (appointed 17 November 2023)

Company registered
number 03502244
Charity registered
number 1068673
Principal and registered Bedford House Fulham Green
office 69-79 Fulham High Street
London, SW6 3JW
Company secretary Prof. Steven Lewis M.D.
Management Director Laura Druce
Independent auditors Griffin Stone Moscrop & Co
Chartered Accountants
Statutory Auditors
21-27 Lamb's Conduit Street
London, WC1N 3GS
Bankers National Westminster Bank plc
1 Market Place
Devizes
Wiltshire, SN10 1HR
Solicitors Hunters, 9 New Square
Lincolns Inn
London, WC2A 3QN
Independent financial Attivo Financial Limited trading as Ashburn Financial Planning Limited
adviser 84 Grange Road
Darlington
County Durham, DL1 5NP

Page 1

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT FOR THE YEAR ENDED 31 DECEMBER 2023

The Trustees (who are also directors of the charity for the purposes of the Companies Act 2006) present their annual report together with the audited financial statements of the World Federation of Neurology ("the Federation" or "WFN") for the year ended 31 December 2023. The annual report serves the purposes of both a Trustees’ report and a directors’ report under company law. The Trustees confirm that the annual report and financial statements of the Federation comply with the current statutory requirements, the requirements of the charitable company's governing document and the provisions of the Statement of Recommended Practice (SORP), applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

Since the Federation qualifies as small under section 382, the strategic report required of medium and large companies under The Companies Act 2006 (Strategic Report and Director's Report) Regulations 2013 is not required.

STRUCTURE, GOVERNANCE AND MANAGEMENT

Constitution

The Federation was incorporated as a charitable company limited by guarantee and not having a share capital on 27 January 1998 and is a registered charity.

The Federation is governed by its Memorandum and Articles of Association.

Methods of appointment or election of Trustees

The nominating committee of the World Federation of Neurology consists of at least three members, usually drawn from different countries. No Trustee may serve on this committee and its proceedings and decisionmaking processes are held in private to avoid any outside pressures and influences. It conducts its business by regular mail and other forms of communication (teleconference, e-mail, fax etc.), and it invites nominations for any vacant Officer or Trustee posts from WFN Member Society Delegates, past and present Trustees/Officers and committee members. Requirements are that a nominee should be a member of a WFN Member Society with a national and international reputation whose contributions to neurology and, as importantly, his or her commitment to the growth and development of the WFN have been substantial. In evaluating nominations, consideration is also given to geography and gender.

Names of individuals, together with confirmation of their willingness to stand for election, a brief CV and evidence of support from their national society, must be submitted to the Secretary General, c/o the Secretariat. In years when officer posts fall vacant, candidates for President, First Vice-President, Secretary General and Treasurer are required to formulate a statement of their goals and objectives for the organisation if elected, and these are published in the Federation's newsletter and on its website at least six months before the annual general meeting at which election takes place. The list of candidates agreed by the committee is also published in World Neurology, the Federation's newsletter, and the WFN website as appropriate at least six months prior to the meeting of the Council of Delegates (COD) and further names may be added to it (subject to review by the committee) if submitted by five or more delegates at least 30 days prior to the council meeting.

The committee, on request, confidentially advises candidates who have not been shortlisted, and their proposers and immediate supporters, of the reasons for their omission. It is recognised that there may be nominees who fully meet the guidelines for selection mentioned above, but who, for a variety of administrative reasons, cannot be included on the published shortlist. Exclusion is in no way indicative of unsuitability and should not be regarded as such.

At the annual general meeting, the delegates of the member societies elect individuals from the list submitted by the nominating committee to fill any vacancies amongst the officers and the elected trustees owing to retirement or expiry of term of office.

Page 2

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

STRUCTURE, GOVERNANCE AND MANAGEMENT (continued)

Organisational structure and decision-making

The Trustees have control of the Federation and its property and funds. The Trustees must hold at least four meetings each year. A quorum is three trustees.

The Trustees may delegate any of their functions to other committees, including a finance committee, each of which comprises three or more individuals appointed by the Trustees and at least one of whom shall be a Trustee. All proceedings of the committees are reported to the trustees.

Because membership of the body of Trustees and of all WFN committees is international, often making it difficult to arrange face-to-face meetings, extensive use is made, wherever possible, of electronic conference calls. The trustees hold these on a monthly basis. The occasions when face-to-face meetings are possible and organised occur during major scientific conferences when many committee members register, at their own expense. Principally, these are the annual meetings of regional or specialist societies such as the American Academy of Neurology and the European Academy of Neurology.

The day-to-day management of the Federation has been delegated to the WFN Secretariat, in London.

Policies adopted for the induction and training of Trustees

Trustees terminating their office are debriefed and a handover to newly elected officers and trustees is facilitated.

New Trustees are made aware by the Secretariat and the president and the SG of the responsibilities attached to the position of charity Trustee and are provided with the comprehensive guidance available on the website of the Charity Commission.

Risk management

The Trustees have assessed the major risks to which the Federation is exposed, in particular those related to the operations and finances of the Federation, and are satisfied that systems and procedures are in place to mitigate exposure to those risks. There are no significant risks to the funding requirements of the Federation due to the unrestricted reserve built up in previous years. Internal risks are minimised by the implementation of procedures for authorisation of all transactions and projects and to ensure consistent quality for all operational aspects of the Federation. The procedures are reviewed periodically to ensure that they still meet the needs of the Federation.

Directors and trustees

The Directors of the charitable company are its Trustees for the purpose of charity law and those persons coopted to the board, and throughout this report and financial statements are collectively referred to as the Trustees. The officers of the Federation are the President, the first Vice-President, the Secretary General and the Treasurer. The Federation may have up to five further trustees, three elected trustees and up to two coopted trustees that are chosen by the Trustees at any time who will hold office until the next annual general meeting. One elected Trustee must retire at each annual general meeting, the longest in office retiring first.

Membership

The membership of the Federation is formed by neurological societies or equivalent bodies throughout the world. Such member societies should have at least five active members in order to be eligible for full membership of the Federation.

Page 3

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

OBJECTIVES AND ACTIVITIES

Objects

The objects of the Federation are to improve health worldwide by promoting education and research in neurology and the prevention and treatment of disorders of the nervous system (“the objects”) by:

Aims and objectives

As the representative body of international neurology, the World Federation of Neurology has sought to create alliances for specific purposes with other neurological organisations on the premise that by broadening its approach and focusing its activities, WFN can have an impact greater than the sum of its individual efforts.

The World Federation of Neurology's foremost principle, driving its policy is one of global involvement, strategic alliances and regional and member society empowerment. This will mean widespread consultation on such matters as nominations for all WFN committees and participation by a large number of stakeholders in the implementation of WFN policy.

Collaboration with the World Health Organization (WHO), and the UN ECOSOC is crucial for the future of neurology and this objective is pursued vigorously.

Activities for achieving objectives

The Federation seeks to achieve its aims and objectives in a number of ways: by being a highly visible, reputable and active body, organising congresses, educational days and symposia, promoting the highest standards of practice in neurology, encouraging professional interaction and dialogue, publishing and distributing information and journals, making travel grants available, establishing training centres in low and low-middle income countries, providing research grants through its grants committee and co-operating and liaising with regional groups, member societies and other bodies.

Public benefit

In setting objectives and planning for activities, and in preparing this report, the trustees have given due consideration to the Charity Commission's general guidance relating to public benefit. The WFN's avowed aim is to improve health worldwide by promoting education and research in neurology and the prevention and treatment of disorders of the nervous system. As noted above, it seeks to do this by undertaking a range of varied activities.

Going concern

After making appropriate enquiries, the trustees have a reasonable expectation that the Federation has adequate resources to continue in operational existence for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

Page 4

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance

Review of activities

World Congress of Neurology (WCN)

The WCN rotates between four regions of the world, all with different health systems, different backgrounds, different neurological challenges, and different needs. WCNs are a valuable forum for exchange of neurological development, science, clinical experience, and education as well as personal trajectories, and allow a forum for mentoring the present and next generation of neurologists.

The last congress took place in Montreal Canada in 2023, and will be followed by Seoul, South Korea in 2025. The election for the congress site in 2027 took place in Montreal and will be Cape Town (South Africa).

In addition to the in persons congresses the WFN continued with a virtual part in Montreal which was highly successful with 1420 participants from 106 countries.

This compensated for the relatively low attendance by the congress by 3536 attendees, which was largely attributed to the visa issue in Canada as well as the high travel costs for low middle- and low-income countries. Equally important the interest of pharma sponsoring was low. In summary there was a very small financial revenue for the WFN, which is needed to support its activities.

The program of the congress was scientifically excellent. It had a speaker distribution of male to female of 60: 40. Interactive sessions and many structural sessions with the WHO, and other international societies were available.

All abstracts are available in a JNS supplement free edition Volume 455, December 2023, several reports are available in World Neurology. The congress is also now available at the e learning hub on the WFN website free of charge, fulfilling the educational mission of the WFN.

For the organisation of congresses, the WFN uses a professional congress organizer “PCO”, for the duration of 3 consecutive congresses. In 2022 a tender process was initiated for application of a PCO for the period following the next WCN in Montreal, Seoul and Cape Town. After an intensive selection, 3 shortlisted candidates were screened by the WFN officers in a transparent and structured interview and Kenes was reappointed for the next period. In addition to the basic work of the PCO also structural meetings with Kenes supporting the further development of the WCN were initiated.

Depending on the high demand of neurological education, and the need for update in between the biennial congresses the WFN decided to opt form an interim meeting between the congresses, termed “The World Federation of Neurology Digital Update”, which will be first held in Sept 2024. It will be a virtual meeting, updating on the most frequent neurological conditions and will also include teaching courses. Financially it is aimed at a low cost production to serve the access from low-income countries.

Education

The WFN continues to support short-term training for young neurologists, through the Department Visit program. The WFN advertises these visits among Member Societies and via extensive social media postings. Several member societies such as Austria, Canada, Germany, Italy, Norway, and Türkiye have participated by hosting young Sub-Saharan African or Latin American neurologists from low and lower-middle-income countries for periods of up to four weeks. For Asia, India is now participating in the department visit program.

The WFN plans to increase the number of Member Societies offering this program, and the Training centre in Cairo has expressed the wish to host participants from the Arab region.

Page 5

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

The WFN supports neurologic training centres in Africa (since 2013) and Mexico City (since 2018) for both general and subspecialty neurologic training to enhance regional education and teaching and empower regions. In addition to one-year fellowships (in general neurology, neuromuscular disease, epilepsy, and stroke), and full 4-year training is possible in 3 centres. The goal is to provide high-quality neurological training centres to fulfil educational needs to trainees from low and lower-middle-income countries from specific regions of the world. In addition to WFN's accreditation of training centres in Rabat (2013), Cairo (2015), and Dakar (2017), the Cape Town Centre was approved to become operational in 2020 with a trainee who started in 2021 and continued his training through 2023 A site visit to the training centre in Cairo was made in 1/2024. Further site visits to each of the WFN training centres are planned for 2024.

The WFN's efforts in Africa are complemented by the accredited training centre in Mexico, serving the Latin American region.

Application for positions in the training centres are announced on the WFN website, and applicants are scrutinized by a committee from the regional representative, the WFN education committee, and representatives from the host department. Once candidates are selected, the WFN provides funds for both one-year fellowships as well as 4-year training. This activity is carried out by funds from the WFN only. Exceptions are contributions from the Association of British neurologists for the Cairo training site, and from one of the WFN specialty groups (International Congress of Neuromuscular Disease), who dedicate part of their surplus to neuromuscular education in Rabat. A future Training Centre is planned for the Asian region which will be offering one year training.

For 2025 the establishment of an Asian Training Centre is planned and has been in development for several years. The final decision regarding location and content with be made with the Asian Regional Society (AOAN).

The WFN and the American Academy of Neurology (AAN) continued the Continuum Program for neurological education in low- and lower-middle-income countries. This highly valued program provides Coordinators with hard and/or digital copies of the Continuum Journal six times a year. Each issue has a different disease-category theme and learning objectives. The WFN intends to continue to add more new coordinators and participants from low and low-middle-income countries going forward. The WFN organizes the distribution of hard copies, has close contacts with coordinators, and reports periodically on activities to the AAN and WFN.

In 2024 the AAN and the WFN decided on a new joint project “Global Advocacy Leadership Program “. This will be targeted on teaching advocacy and leadership skills worldwide, for 20 candidates from low and low-middleincome countries. The program will have two in-person meetings (at the AAN Annual Meeting in San Diego, and the WFN’s World Congress of Neurology in Seoul), and a series of interim virtual meetings. The outcome is the development of advocacy and leadership trained persons from low middle- and low-income countries.

E-learning Days, which are virtual one-day courses in neurology, primarily for neurologists and healthcare workers in Africa held in English and French, were introduced in 2020. The first E-learning Day topic was stroke. The second E-learning Day in 2021 was focused on epilepsy, followed by movement disorders in 2022. The 4th e-learning day was held in 2/2024 on neuropathies eLearning hub as permanent educational material for neurologists and neurological trainees from across the globe. For the Asian region (AOAN) a successful eLearning day was held in cooperation with the AOAN in 2023.

The WFN partnered with the International Headache Society (IHS) and IHS-Global Patient Advocacy Coalition (GPAC) on an E-learning programme on Headache. The headache e-learning day was successfully held in 2023 and will be continued in 2024.

The WFN plans to continue these E-learning days annually and continue to grow with the delivery of E-learning programs in other regions in need.

Page 6

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

The WFN continues to financially support the European Academy of Neurology (EAN) in holding Regional Training Courses (RTCs) in Sub-Saharan Africa. In 2021 the RTC was done virtually. In 2022, the RTC was held in Douala, Cameroun on October 20, 2022, in conjunction with the African Academy of Neurology Congress which occurred October 21-23rd. The regional AFAN African Congress of Neurology (2022) was also sponsored by the WFN. The RTC 2023 took place in Dar es Salam and was also sponsored by the WFN and included 2 speakers supported by the WFN.

For their yearly congress, the Latin American Pan American Federation of Neurological Societies (PAFNS) requested support from the WFN. A support of $10,000 was donated by the WFN for this congress, which was successfully held in Lima, Peru. At this congress also a meeting of the WFN Specialty Group on Tropical Neurology took place, which was cost-neutral to the WFN.

The International Congress of Neuromuscular Disease (ICNMD) is a successful biennial congress, organized by the WFN Specialty Group on Neuromuscular Disease, and last held in person in Brussels with 1400 participants, had a virtual update meeting in December in 2023. This was attended by 300 participants and was very successful. The revenue was shared with the congress PCO and will help to finance another additional WFN training centre position in Rabat, Morrocco. The next ICNMD will be held in Perth, Australia, followed by Florence, Italy in 2026.

To address the global shortage of neurologists (https://www.who.int/publications/i/item/atlas-country-resourcesfor-neurological-disorders) shortages, the WFN is actively working on developing a Core Curriculum for global neurologic training. The aim is to develop a practical and useful global neurological core curriculum for training that addresses the minimal required knowledge, skills, and overall competencies for neurologists, recognizing the regional variations in infrastructure including departmental and hospital resources and funding as well as variations in spectrums of diseases.

A regionally inclusive WFN Core Curriculum working group has been formed and has had several active meetings, with subgroups working on the following major aspects of the initiative: 1) Health system structures (e.g., those physical and institutional/regional structures needed to support a neurology training program); 2) The content of the curriculum (e.g. the skills and competencies required of a neurology trainee to be developed during training); and 3) The structure of the curriculum (e.g., those rotations and experiences required to attain competency), including prerequisite training/skills, the duration of neurology training, specific rotations, and any final assessment. The team is also reviewing any current regional/national curricula and training guidelines already in place, while discussing the curricular components that can be deemed achievable to create a welltrained neurological workforce applicable to lower-resourced settings. The plan is to have the draft global curriculum available for review by the end of calendar year 2024.

The goal of the WFN Global Neurological Core Curriculum is to provide a suggested practical framework for neurological training and competency, particularly in lower-resourced settings, that is intended to be of value to inform local educators and their health system structures to promote quality neurologic training but not intended to be an edict or mandate. It will also be flexible enough to be updatable as needs change and the field of neurology evolves.

The WFN eLearning Hub was initiated in 2021 with the aim of being a premier international hub for accessing high-level educational activities from sources across the world. WFN’s own educational materials, such as those that are part of the World Congress of Neurology, are posted directly on the WFN website for access via the eLearning Hub. In addition to other content such as the WFN’s global archive of topics, the content from the WCNs and the neuromuscular (ICNMD) congresses are available. There are also links to educational videos hosted at academic centres across the world that are outside of the WFN. The WFN has reorganized the structure of this important hub to enhance access to free global educational activities worldwide.

Page 7

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

World Brain Day (WBD)

For 2022 the topic of the WBD was “Brain Health” following and aligning with the Brain Health activities of the WHO. The organizational committee consisted out of the WFN regions (Africa, Asia, Europe, Latin America, North America and the Pan-Arab region). This global involvement increased the worldwide attention. A successful webinar was held, and promotional advertising occurred throughout the campaign. Media reports and activities in a large number of national societies were conducted. Newspaper items and electronic postings were made through social media. For 2023 the topic of Brain health was continued, and “disability” was added which raised the importance for disability in neurological diseases. For 2024 the initiative on Brain health will be continued and “prevention” is added. This is important as it is a concurrent topic of the 5 pillars of the Intersectoral global action plan on epilepsy and other neurological disorders.

Brain Health Initiative

The Brain Health Initiative was launched in 2021 as a multi-part programme meant to simplify the complex subjects related to neurology in an effort to maintain, improve and promote brain health globally. Each unit of the Brain Health Initiative provided a free, comprehensive information on a variety of topics related to brain health. The initiative on Brain health was continued with the WBD 2022, and joint publications with the WHO (doi: 10.1016/j.jns.2022.120337), and the WFN has participated at the EAN brain health summit 2022 (https://www.ean.org/ean/advocacy/brain-health/brain-health-summit), and in 2023 , as well as in 2024.

The WFN was also invited to a Brain health summit hosted by the American Academy of Neurology, in Sept 2023 in Washington.

Global Neurology Alliance (GNA)

The GNA is an alliance of regions, SGs, World societies and topic societies. The common aim is to promote and foster neurology. A meeting of the GNA was held in Montreal, 2023.

Participation in International meetings

Joint invited meetings took place with the WSO, the EAN, ILAE, the SIN and several video messages for meetings could be delivered.

Patient and Advocacy

The WFN increases efforts to include patient and advocacy organisations. Several sessions were held in Montreal, and a “patient day” preceded the meeting, providing an excellent interaction with the local society and patient organisations.

Students

The WFN is supportive of student organisations as the IFSMA, and invited students to participate at the WCN,

Publications

To keep neurologists across the world informed, the WFN publishes a bimonthly newsletter, World Neurology. World Neurology is posted on the WFN website and sent by e-mail on request to almost 30,000 individual specialists belonging to WFN Member Societies.

The Journal of the Neurological Sciences (JNS) is the official Journal of the World Federation of Neurology. Published by Elsevier, the JNS provides a medium for the prompt publication of peer-reviewed, original articles in neurology and neuroscience from around the world. JNS accepts many types of manuscripts for consideration including original research papers, short communications, reviews, book reviews, letters to the Editor, opinions and editorials. Topics considered are from neurology-related fields that are of interest to practicing physicians around the world. The impact factor of the JNS increased in 2022 (to 4.553). In 2023 this tendency continued and the WFN promotes the journal on the website and by publishing articles.

Prof Steven Lewis has become an associated editor of the JNS journal.

Page 8

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

In 2023 the preparatory work for an integrative part of the JNS, the WFN service pages were initiated and appeared in 2023 for the first time. It is intended to give readers information on important WFN articles and invites contributions (Link). Edited by SL and WG.

The WFN's open access journal, published by Elsevier, is eNeurologicalSci. It provides a medium for the publication of original articles in neurology and neuroscience from around the world. It has a steady upstream in submissions as an established journal. The authorship is from around the world, currently with a predominance of Asia, US, and Europe. The eNS cite score has lately risen to 3.1 in 2022. In 2023, articles from eNS had been downloaded more than 150,000 times.

A joint publication with the WHO on Brain health was published in the JNS (doi:10.1016/j.jns.2022.120337).

The WFN jointly with ILAE and IBE held a webinar on the introduction of the Intersectoral Global Action Plan (IGAP).

Website

The WFN website serves as a platform for the WFN (about us) the distribution of news, recommended publications and also serves as a link to all WFN publications, including all issues of World Neurology. Changes to the surface and structure are permanently ongoing. The successful “Covid” website was converted in a website for infectious diseases, with monthly updates. As a new feature a relaunch of the e learning hub was initiated in 2023, ending in 2024.

Social media

The WFN uses social media on a regular basis to send news on the WFN, the WCN and important news regarding the field of neurology. The WFN is supported by the PCO Kenes in this ongoing and very important activity.

Needs Registry

In partnership with its member societies, the World Federation of Neurology compiled an inventory of the most important deficiencies worldwide causing inequalities in the prevention and care of neurological disorders. The WFN registry of needs provides an essential world view that will assist the WFN in identifying disparities in the delivery and quality of neurological care and inform decisions prioritizing and targeting future remedying efforts. Topics include:

World Health Organisation (WHO)

The WFN is a non-State actor in official relations at WHO. The WHO is a Non state actor of the WHO and has been confirmed to continue this position until 2026.

The Triannual plan for collaboration has been developed by the WHO in collaboration with the WFN.

In November 2020, the WHO Executive Board accepted the recommendation of the World Health Assembly (WHA) to adopt Resolution WHA 73. 0. This resolution called for the development of an Intersectoral Global Action Plan (IGAP) to tackle epilepsy and other neurological disorders through comprehensive actions to detect, prevent, care, treat, and rehabilitate people with epilepsy and other neurological disorders, as well as ensuring their social, economic, educational, and inclusion needs. The intervention in support of IGAP was made by the WFN President at the 150th meeting of the WHO Executive board.

Page 9

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

The IGAP was approved at the 75th WHA in Geneva in 2022 (https://www.who.int/about/governance/worldhealth-assembly/seventy-fifth-world-health-assembly), and an intervention was made by the WFN. In 2023 the WHO BH unit took efforts to develop the IGAP toolkit to help its implementation. The WHO supported this as a donor. The release of the IGAP Tool Kit is planned for 2024.

Other cooperations with the WHO Brain Health Unit continue and focus on the implementation of the IGAP. Meetings with the WHO Brain Health Unit, either in person or virtually ensued. The WFN participated in the Essential medicine List (EML) meeting in 2023, the WHO rehabilitation meeting in 2023, and participated as a stakeholder in WHOs Defeat meningitis program. The WHO participated in the WBD 2023, and was also to give a plenary lecture ate the WCN in Montreal. During the WHO Executive Board meetings and WHA meetings the WFN made several successful interventions.

During the first wave of the COVID 19 pandemic, the WHO asked the WFN, as the organisation directly representing neurology and neurologists, to be represented on the WHO-formed Neurology and COVID-19 Global Forum. The WFN continues to have involvement in these groups which target to explore the CNS and PNS effects of Covid.

Special Consultative status with the United Nations Economic and Social Council ECOSOC

In 2022 the WFNs application for a Special Consultative status with the United Nations Economic and Social Council ECOSOC was accepted and the WFN attended the UN ECOSOC meeting for the first time in December 2022 and gave an intervention. During 2023 the WFN attended 2 meetings in New York, giving interventions on equity, access to care and “End TB”. Further preparations were made to allow further engagement for the UN ECOSOC. A successful intervention in May 2004 was made, another one is planned for July in order to promote brain health.

Council of Delegates (CoD) meeting in Montreal 2023

The WFN’s Annual General Meeting, the Council of Delegates (Hybrid) Meeting 2023, was held on Sunday 15th October 2023.

It was a hybrid meeting attended by 12 attending the congress, and 61 delegates online. After the introduction of the president, vice president and secretary-general, the committees and subcommittees gave their reports. The nomination committee chair announced that 1 position that of an elected trustee will be at disposition for the next COD meeting in 2024.

The treasurer’s report gave an overview on the budget and financial situation of the WFN.

The announcement of the 2023 election results were announced: Pr Morris Freedman was elected the new treasurer taking up office from 1.1. 2024, and Prof Mohammad Wasay as an elected trustees taking office in October 2023. The president welcomed the new members of the trustee board, and thanked the outgoing treasurer Prof R. Stark, and Prof Freedman as an elected trustee for their work.

For the WCN 2027 after announcement and bidding from Societies from Senegal, Kenya, and South Africa finally after extensive feasibility assessment, and withdrawal from Kenya and Senegal, Cape Town was elected by the delegates.

Regions

The Regions of the WFN are Africa, Asia, Europe, Latin America, North America and the Pan-Arab region. They have been involved on a regular basis with 3 monthly meeting with the trustees. In addition, a virtual strategy meeting with the regions was hosted in January 2023. Regional sessions also took place during the WCN congress in Montreal.

Page 10

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

WFN Committees

The World Federation of Neurology provides a forum for members of the world’s neurological societies to meet, learn, and work together through its 11 committees and 20 sub-committees.

The WFN Committees are important advisory bodies to the WFN and carry out delegated functions on behalf of the Trustees and Secretariat. All Committees are under supervision of the Trustees, except for the nominating committee which is fully independent in its decision process.

All committees consist of members from the regions upon recommendation from the regions. The gender distributions were paid attention and is now about 40:60 %, aiming at 50: 50.

Specialty Groups (SGs)

Are working groups of the WFN. The individual SGs engage in educational activities and cooperate with educational activities of the WFN such as the structure and content of the biennial World Congress of Neurology (WCN) including WFN teaching courses and the biennial Tournament of the Minds and the World Brain Day. Some SGs organize their own congresses, such as the International Congress on Neuromuscular Diseases (ICNMD) and congresses related to motor neuron disease and neurosonology.

The SGs are part of the WFN, and their chairs and members need approval from the trustees. An MOU signed by the chair defines the reciprocal relationship in detail.

Investment performance

The Federation's funds are treated as two portions with different aims, as detailed under the section below headed "Investment policy and objectives".

The short-to medium-term working capital is retained in bank deposit accounts and fixed-term bonds. Nominal capital values have been maintained and competitive interest added.

Cash has been managed carefully with an eye to liquidity needs, currencies of income and expected expenditure. Previously, the Federation held fixed term deposit accounts via Transact, but this facility is no longer available. At year end, there were £200,000 held in a two-year fixed term deposit account paying 4.71% gross interest maturing on 2nd December 2024. The remainder of the cash at Transact, which amounts to £732,234 is instantly accessible which, due to Bank of England base rate rising from 3.5% at the start of the year to 5.25% by December 2023, was receiving gross, variable interest of 2.64% in January 2023 rising to 4.86% by the year end.

With fixed term accounts maturing during 2023, the Transact cash accounts returned 3.74% net of costs over the year.

In addition, there was cash at NatWest with £1,391,422 at year end. To match likely expenditure needs, liquid cash at the bank was held predominately in Sterling, US Dollars and a Euro account. There were also £200,000 held in a one-year fixed term account paying 4.72%. This matures on September 30, 2024.

The longer-term reserve fund, to which £1.5m had been allocated before 2017 (£1m in 2010 and £500k in 2014) with a further £312,000 added during 2017 and £500,000 in 2018 is invested in a range of funds containing government bonds (gilts), high-quality corporate bonds, other fixed-interest securities and global equities. Whilst access to this fund is vital, and a conservative risk profile is to be maintained, the Trustees' objective is to generate higher medium-term returns than those available from cash deposits in the current low interest rate environment.

Page 11

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Achievements and performance (continued)

This fund, which has increased in value by 5% to just over £3.2m in the year to the accounting date, has been invested in line with the agreed conservative asset split of 60% in bonds, fixed-interest securities and gilts, and 40% in global equities. This equated to bond and cash holdings of around £1.92m at the end of the accounting period, and £1.28m in equity funds.

The £1.28m or so in equity funds provides dividend income but is held predominantly in the hope of inflation beating capital growth to support the Federation's work in the longer term. The £1.92m in bond funds is intended to reduce the volatility of the investment portfolio as a whole and fulfil the twin roles of income production to support future projects and maintaining reserves in case of a downturn in congress income in the future.

Following falls in value in both equity and bond markets, 2023 saw positive returns across the board, as inflation came under control and interest rate rises becoming less likely. Whilst returns were positive, there was some discrepancy between markets, with the US market, as measured by the S&P 500, was up 21.90% during 2023. In the UK the FTSE100 lagged being up just 2.4%.

Having fallen by 7% during 2022, the fixed income funds showed some recovery, returning around 4% during the year by way of capital growth (2.3%) and interest (1.7%).

The UK pound, having fallen around 10% against the dollar in 2022, gained around 5.5% in 2023.

Looking at the long-term portfolio as a whole, we have seen total positive returns in the year of 5% taking into account the timing of money in and money out; consisting of reinvested income of approximately 2.3% and capital values increasing by 4.7%.

Pay policy

The WFN Board of Trustees reviews staff pay annually and in 2023 provided a pay rise of 10.1%.

FINANCIAL REVIEW

Reserves policy and funding position

The Federation has a source of income from the biennial world congress. The other main sources of income, such as membership dues, royalty income and investment income, are received either monthly or annually.

At December 31, 2023 the Federation's unrestricted funds not invested in tangible fixed assets and excluding designated funds totalled £5,183,458. The Trustees consider it prudent for the Federation to maintain an available reserve of liquid or readily accessible funds in the region of one to two times its normal annual expenditure. This reserve would be used to enable the Federation to plan and execute in good order either a reduction in its activities or an improvement in its income stream.

Page 12

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Investment policy and objectives

Under its Memorandum and Articles of Association, the Federation has the power to make any investment that it sees fit. The Trustees, mindful of their charitable goals, are concerned to ensure they hold in balance the following objectives:

In this respect they look to hold a range of deposits and investments which are well-diversified and suitable. They appreciate the need for advice and, whilst not delegating discretionary investment management to their advisers, Attivo Financial Limited, they ensure investments are reviewed regularly.

The Trustees continue to believe it is appropriate to set aside a significant portion of those Federation assets, which they anticipate will not be required to meet its objects within the next 3 to 4 years, and to hold them as a long-term reserve fund. Although invested for the longer term, this fund is not restricted in its use, and should remain accessible. This longer-term portfolio is invested in a range of widely-diversified passive funds with the aim of achieving a long-term return in excess of inflation. Broadly, 60% is held in low-risk gilt and bond funds, with the remaining 40% in equity funds. It is understood this may result in volatility in the short term, but gives better prospects of long-term growth.

The remainder of the Federation's capital is to be held predominately in liquid bank deposits, fixed-term deposits, or other fixed-interest securities. Capital protection, allied with reliable and competitive interest, is the primary investment objective of this element.

Financial activities and affairs

For 2023 the Grants Committee continued its work and two grants totalling a value of $42,400 USD were approved.

Junior Travelling Fellowships (JTF) to enable young neurologists to attend international conferences were awarded again in 2023. Twenty one JTF were funded at £1,000 per JTF.

Training positions designed to improve the quality of neurological practice in areas with limited resources have been established in Rabat, Cairo, Dakar, Cape Town and Mexico to allow the training of neurologists from other parts of Africa and in Mexico to allow the training of neurologists from other parts of Latin America. In 2021, mobility restraints due to the pandemic limited training to 2 trainees and in 2022 to 3 trainees. In 2023 there were four trainees, of which one trainee was in Dakar and two were in Rabat with a total investment of 24,328 Euros. There was one trainee in Cape Town with an investment of 18,550 USD.

The statement of financial activities on page 21 shows total incoming resources of £722,156 and total expenditure of £931,000 in the year under review, resulting in overall net deficit of £70,175.

In the opinion of the trustees the overall financial state of affairs of the Federation is satisfactory and adequate to fulfil its obligations.

The 2023 World Congress of Neurology realized a gain of £2,870. Despite the small gain, the finances of the WFN remain healthy with net assets of just over £5.4m at the end of 2023.

Page 13

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

PLANS FOR FUTURE PERIODS

The major plan for education and training is to consolidate and expand the training centres beyond Africa. The centre for Latin America is in Mexico City in addition to four centres in Africa, Rabat and Dakar (francophone) and Cairo and Cape Town (anglophone). Plans are underway for a WFN-accredited training centre in Asia; the country and site are still to be determined.

Other enhancements to education include the establishment of a department visit program in India, and additional eLearning webinars, particularly aimed for learners in sub-Saharan Africa but accessible throughout the world, in addition to the eLearning courses on Headache and Movement Disorders.

An educational project has been the development of an eLearning Hub, showcasing and providing links to online video-based neurological educational programs throughout the world; this resource continues to expand with increasing contributions of online educational programs from the WFN regions.

The Continuum program also continues to be honed and expanded, with ongoing collaboration with the AAN, to enhance the distribution and use of this important educational resource to neurologists in low- and lower-middle income countries in all regions.

Another major WFN initiative planned is the development of a practical, universally useful Global Neurology Core Curriculum for neurologic training, addressing the required knowledge, skills, and overall competencies required for neurologists and neurologic training worldwide, while recognizing regional variations in resources, funding and other infrastructure, and spectrum of diseases.

The Federation has worked actively with WHO in establishing the Intersectoral Global Action Plan on Epilepsy and other Neurological Disorders (IGAP). The Federation has committed to support the development of a toolkit for the implementation of IGAP at an expected cost for 2023 of £103,681.

MEMBERS' LIABILITY

The member societies of the Federation guarantee to contribute an amount not exceeding £1 per member society to the assets of the charity in the event of winding up.

Page 14

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

TRUSTEES' REPORT (CONTINUED) FOR THE YEAR ENDED 31 DECEMBER 2023

Statement of Trustees' responsibilities

The Trustees (who are also the directors of the Federation for the purposes of company law) are responsible for preparing the Trustees' Report and the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice).

Company law requires the Trustees to prepare financial statements for each financial . Under company law, the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the Federation and of its incoming resources and application of resources, including its income and expenditure, for that period. In preparing these financial statements, the Trustees are required to:

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the Federation's transactions and disclose with reasonable accuracy at any time the financial position of the Federation and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the Federation and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

PROVISION OF INFORMATION TO AUDITORS

Each of the persons who are Trustees at the time when this Trustees' Report is approved has confirmed that:

Auditors

A resolution to re-appoint Griffin Stone Moscrop & Co, Chartered Accountants and Statutory Auditors, as auditors of the company will be proposed at the annual general meeting.

Approved by order of the members of the board of Trustees on 11 September 2024 and signed on their behalf by:

................................................

Prof. Wolfgang Grisold President

Page 15

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF WORLD FEDERATION OF NEUROLOGY

Opinion

We have audited the financial statements of World Federation of Neurology (the 'federation') for the year ended 31 December 2023 which comprise the Statement of Financial Activities, the Balance Sheet, the Statement of Cash Flows and the related notes, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the Trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the charitable company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the Trustees with respect to going concern are described in the relevant sections of this report.

Page 16

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF WORLD FEDERATION OF NEUROLOGY (CONTINUED)

Other information

The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' Report thereon. The Trustees are responsible for the other information contained within the Annual Report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinion on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

Matters on which we are required to report by exception

In the light of our knowledge and understanding of the charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Trustees' Report.

We have nothing to report in respect of the following matters in relation to which Companies Act 2006 requires us to report to you if, in our opinion:

Page 17

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF WORLD FEDERATION OF NEUROLOGY (CONTINUED)

Responsibilities of trustees

As explained more fully in the Trustees' Responsibilities Statement, the Trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the Trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the financial statements, the Trustees are responsible for assessing the charitable company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Page 18

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF WORLD FEDERATION OF NEUROLOGY (CONTINUED)

Auditors' responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

As part of an audit in accordance with ISAs (UK), we exercise professional judgment and maintain professional scepticism throughout the audit. We also:

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

Page 19

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF WORLD FEDERATION OF NEUROLOGY (CONTINUED)

Use of our report

This report is made solely to the charitable company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and its members, as a body, for our audit work, for this report, or for the opinions we have formed.

Reema Mistry ACA (Senior Statutory Auditor)

for and on behalf of

Griffin Stone Moscrop & Co

Chartered Accountants Statutory Auditors 21-27 Lamb's Conduit Street London, WC1N 3GS

11 September 2024

Page 20

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

STATEMENT OF FINANCIAL ACTIVITIES (INCORPORATING INCOME AND EXPENDITURE ACCOUNT) FOR THE YEAR ENDED 31 DECEMBER 2023

Note
Income from:
Donations and legacies
3
Charitable activities
4
Other trading activities
5
Investments
6
Total income
Expenditure on:
Raising funds
7
Charitable activities
8
Total expenditure
Net expenditure before net
(losses)/gains on investments
Net gains/(losses) on investments
Net movement in funds
Reconciliation of funds:
Total funds brought forward
Net movement in funds
Total funds carried forward		 Unrestricted
funds
2023
£
811
411,643
192,462
117,240
722,156
12,105
913,957
926,062
(203,906)
138,669
(65,237)
5,259,487
(65,237)
5,194,250		 Restricted
funds
2023
£
-
-
-
-
-
-
4,938
4,938
(4,938)
-
(4,938)
261,905
(4,938)
256,967		 Total
funds
2023
£
811
411,643
192,462
117,240
722,156
12,105
918,895
931,000
(208,844)
138,669
(70,175)
5,521,392
(70,175)
5,451,217		 Total
funds
2022
£
827
403,190
151,381
64,299
619,697
12,122
680,359
692,481
(72,784)
(250,348)
(323,132)
5,844,524
(323,132)
5,521,392

The Statement of Financial Activities includes all gains and losses recognised in the year.

The notes on pages 24 to 44 form part of these financial statements.

Page 21

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital) REGISTERED NUMBER: 03502244

BALANCE SHEET AS AT 31 DECEMBER 2023

2023 2023 2022
Note £ £
Fixed assets
Tangible assets 13 10,311 7,438
Investments 14 3,169,584 3,030,915
3,179,895 3,038,353
Current assets
Debtors 15 1,179,767 1,238,708
Cash at bank and in hand 1,592,034 1,338,438
2,771,801 2,577,146
Creditors: amounts falling due within one
year 16 (500,479) (94,107)
Net current assets 2,271,322 2,483,039
Total net assets 5,451,217 5,521,392
Charity funds
Restricted funds 18 256,967 261,905
Unrestricted funds 18 5,194,250 5,259,487
Total funds 5,451,217 5,521,392

The Trustees acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to entities subject to the small companies regime.

The financial statements were approved and authorised for issue by the Trustees on 11 September 2024 and signed on their behalf by:

................................................

Prof. Wolfgang Grisold

President

The notes on pages 24 to 44 form part of these financial statements.

Page 22

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

STATEMENT OF CASH FLOWS FOR THE YEAR ENDED 31 DECEMBER 2023

Cash flows from operating activities
Net cash used in operating activities
Cash flows from investing activities
Dividends, interests and rents from investments
Purchase of tangible fixed assets
Purchase of investments
Net cash provided by investing activities
Cash flows from financing activities
Net cash provided by financing activities
Change in cash and cash equivalents in the year
Cash and cash equivalents at the beginning of the year
Cash and cash equivalents at the end of the year
The notes on pages 24 to 44 form part of these financial statements		 2023
£
142,061
117,240
(5,705)
-
111,535
-
253,596
1,338,438
1,592,034		 2022
£
278,311
64,299
(7,100)
(21,989)
35,210
-
313,521
1,024,917
1,338,438

Page 23

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

1. General information

The Federation is a company limited by guarantee, which was incorporated in England, and is registered as a charity with the Charity Commission of England and Wales. The members of the company are the member societies. In the event of the Federation being wound up, the liability in respect of the guarantee is limited to £1 per member society. The registered office is displayed on the company information page.

The financial statements are prepared in sterling and are rounded to the nearest £1.

2. Accounting policies

2.1 Basis of preparation of financial statements

The financial statements have been prepared in accordance with the Charities SORP (FRS 102) - Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019), the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) and the Companies Act 2006.

World Federation of Neurology meets the definition of a public benefit entity under FRS 102. Assets and liabilities are initially recognised at historical cost or transaction value unless otherwise stated in the relevant accounting policy.

2.2 Going concern

After making appropriate enquiries, the Trustees have a reasonable expectation that the Federation has adequate resources to continue in operational existence for the next twelve months. For this reason they continue to adopt the going concern basis in preparing the financial statements.

2.3 Fund accounting

General funds are unrestricted funds which are available for use at the discretion of the Trustees in furtherance of the general objectives of the Federation and which have not been designated for other purposes.

Designated funds comprise unrestricted funds that have been set aside by the Trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements.

Restricted funds are funds which are to be used in accordance with specific restrictions imposed by donors or which have been raised by the Federation for particular purposes. The costs of raising and administering such funds are charged against the specific fund. The aim and use of each restricted fund is set out in the notes to the financial statements.

Investment income, gains and losses are allocated to the appropriate fund.

Page 24

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

2. Accounting policies (continued)

2.4 Income

All income is recognised once the Federation has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

Investment income is accounted for as received. The Federation’s share of any surplus arising from a world congress is estimated until final accounts of that congress become available, at which time an adjustment is made for the difference between the Federation’s estimated and actual share of the surplus. All other income including membership dues, royalty income, grant and donations are recognised once the Federation has entitlement to the income, it is probable that the income will be received and the amount of income receivable can be measured reliably.

Where a donor specifies that a donation or grant given to the Federation is for a particular restricted purpose, or where funds have been raised for a particular restricted purpose, this income is included in the incoming resources of the appropriate restricted fund.

2.5 Expenditure

Expenditure is recognised once there is a legal or constructive obligation to transfer economic benefit to a third party, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably.

All expenditure is accounted for on an accruals basis. All expenses including support costs and governance costs are allocated to the applicable expenditure headings.

Expenditure on raising funds includes all expenditure incurred by the Federation to raise funds for its charitable purposes and includes costs of all fundraising activities events and non-charitable trading.

Expenditure on charitable activities is incurred on directly undertaking the activities which further the Federation's objectives, as well as any associated support costs.

Grants payable are charged in the year when the offer is made except in those cases where the offer is conditional, such grants being recognised as expenditure when the conditions attaching are fulfilled. Grants offered subject to conditions which have not been met at the year end are noted as a commitment, but not accrued as expenditure.

2.6 Interest receivable

Interest on funds held on deposit is included when receivable and the amount can be measured reliably by the Federation; this is normally upon notification of the interest paid or payable by the institution with whom the funds are deposited.

Page 25

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

2. Accounting policies (continued)

2.7 Foreign currencies

Monetary assets and liabilities denominated in foreign currencies are translated into sterling at rates of exchange ruling at the reporting date.

Transactions in foreign currencies are translated into sterling at the rate ruling on the date of the transaction.

Exchange gains and losses are recognised in the Statement of financial activities incorporating income and expenditure account.

2.8 Taxation

The Federation is considered to pass the tests set out in Paragraph 1 Schedule 6 of the Finance Act 2010 and therefore it meets the definition of a charitable company for UK corporation tax purposes. Accordingly, the Federation is potentially exempt from taxation in respect of income or capital gains received within categories covered by Chapter 3 Part 11 of the Corporation Tax Act 2010 or Section 256 of the Taxation of Chargeable Gains Act 1992, to the extent that such income or gains are applied exclusively to charitable purposes.

2.9 Tangible fixed assets and depreciation

Tangible fixed assets are initially recognised at cost. After recognition, under the cost model, tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses.

Depreciation is charged so as to allocate the cost of tangible fixed assets less their residual value over their estimated useful lives.

Depreciation is provided on the following basis:

2.10 Investments

Fixed asset investments are a form of financial instrument and are initially recognised at their transaction cost and subsequently measured at fair value at the Balance Sheet date, unless the value cannot be measured reliably in which case it is measured at cost less impairment. Investment gains and losses, whether realised or unrealised, are combined and presented as ‘Gains/(Losses) on investments’ in the Statement of Financial Activities incorporating income and expenditure account.

All gains or losses on fixed asset investments are accounted for when identified.

2.11 Stocks

Stocks are valued at the lower of cost and net realisable value after making due allowance for obsolete and slow-moving stocks. Cost includes all direct costs and an appropriate proportion of fixed and variable overheads.

Page 26

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

2. Accounting policies (continued)

2.12 Debtors

Trade and other debtors are recognised at the settlement amount after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

2.13 Cash at bank and in hand

Cash at bank and in hand includes cash and short-term highly liquid investments with a short maturity of three months or less from the date of acquisition or opening of the deposit or similar account.

2.14 Liabilities and provisions

Liabilities are recognised when there is an obligation at the Balance Sheet date as a result of a past event, it is probable that a transfer of economic benefit will be required in settlement, and the amount of the settlement can be estimated reliably.

Liabilities are recognised at the amount that the Federation anticipates it will pay to settle the debt or the amount it has received as advanced payments for the goods or services it must provide.

Provisions are measured at the best estimate of the amounts required to settle the obligation. Where the effect of the time value of money is material, the provision is based on the present value of those amounts, discounted at the pre-tax discount rate that reflects the risks specific to the liability. The unwinding of the discount is recognised in the Statement of Financial Activities as a finance cost.

2.15 Financial instruments

The Federation only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value with the exception of bank loans which are subsequently measured at amortised cost using the effective interest method.

2.16 Operating leases

Rentals paid under operating leases are charged to the Statement of Financial Activities on a straight line basis over the lease term.

2.17 Pensions

The Federation contributes to personal pension plans for each of its employees. The pension cost to the Federation is charged to the statement of financial activities on the basis of a constant percentage of the employee earnings.

Page 27

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

3. Income from donations and legacies

Unrestricted
funds
2023
£
Donations
811
Total 2022
827
Income from charitable activities
Unrestricted
funds
2023
£
Share of surplus from the XXVI World Congress of
Neurology
2,870
Royalties receivable
382,396
Share of surplus from the International Congress on
Neuromuscular Diseases
26,377
Total 2023
411,643
Total 2022
403,190		 Total
funds
2023
£
811
827
Total
funds
2023
£
2,870
382,396
26,377
411,643
403,190		 Total
funds
2022
£
827
Total
funds
2022
£
-
368,024
35,166
403,190

4. Income from charitable activities

Page 28

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

5. Income from other trading activities

Income from fundraising events

Unrestricted
funds
2023
£
National membership dues
192,462
Total 2022
151,381		 Total
funds
2023
£
192,462
151,381		 Total
funds
2022
£
151,381

6. Investment income

Unrestricted
funds
2023
£
Income from listed investments
81,776
Bank and other interest
35,464
Total 2023
117,240
Total 2022
61,449		 Restricted
funds
2023
£
-
-
-
2,850		 Total
funds
2023
£
81,776
35,464
117,240
64,299		 Total
funds
2022
£
55,235
9,064
64,299

7. Investment management costs

Unrestricted
funds
2023
£
Commission and independent financial adviser's fees and
expenses
12,105
Total 2022
12,122		 Total
funds
2023
£
12,105
12,122		 Total
funds
2022
£
12,122

Page 29

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

8. Analysis of expenditure by activities

Charitable activities
Total 2022		 Activities
undertaken
directly
2023
£
347,976
219,442		 Grant
funding of
activities
(Note 9)
2023
£
91,826
76,524		 Support
costs
(Note 8)
2023
£
479,093
384,393		 Total
funds
2023
£
918,895
680,359		 Total
funds
2022
£
680,359

Analysis of direct costs

Africa Project costs
Publishing costs
Website and computer costs
COD and standing committees (including meetings, travel and CME costs)
Research groups
Total 2023		 Total
funds
2023
£
14,605
59,182
67,246
108,522
98,421
347,976		 Total
funds
2022
£
41,497
58,837
47,586
71,522
-
219,442

Page 30

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

8. Analysis of expenditure by activities (continued)

Analysis of support costs

Website and computer costs
Secretarial and office expenses
Insurance
Plaques and medals
Bank charges
Loss/(Gain) on exchange
Office rent and services
Accountancy charges
PR and advertising
Recruitment expenses
Staff costs
Depreciation
Sale of assets
Governance costs
Total 2023		 Total
funds
2023
£
4,206
29,253
2,288
2,017
3,072
33,731
45,728
6,396
31,375
-
211,590
2,833
-
106,604
479,093		 Total
funds
2022
£
3,866
23,245
1,375
-
3,273
(78,648)
60,972
6,462
31,100
774
255,666
1,687
1,032
73,589
384,393

Governance costs included above consist of:

9. Analysis of grants

Grants expenditure
Total 2022		 Grants to
institutions
2023
£
51,239
54,524		 Grants to
individuals
2023
£
40,587
22,000		 Total
funds
2023
£
91,826
76,524		 Total
funds
2022
£
76,524

Page 31

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

Grants to institutions

2023 2023 2022
Name of institution Grant description £ £
Clinical profile of patients with X-linked
dystonia parkinsonism in south-central
Dr A Closas Mindanao, Phillipines (18,505) -
Improving lumbar puncture (LP) practice in
two African countries (Ethiopia &
Cameroon): an interventional and feasibility
Addis Ababa University pilot study - 12,407
Development and Piloting of a National
Registry for Pregnant Mothers on
Antiepileptic drug treatment and outcome of
babies using an Open source Web-based
Platform (AED Registry of Pregnant
University of Moratuwa Mothers, Sri Lanka) - 20,678
University Rabat, Morocco Grant for Teaching centre 15,242 7,626
Cheikk Anta Diop University,
Dakar Grant for Teaching centre 6,149 -
University of Stellenbosch,
Cape Town Grant for Teaching centre 15,046 13,813
Epilepsy in Sri Lanka: Prevalence,
Ministry of Health Neurology, treatment gap, and associated factors of
Sri Lanka untreated epilepsy. 17,596 -
Anto-Tuberculosis drug resistance in
District Headquarters, central nervous system Tuberculosis: A
Nankana Hospital, Pakistan prospective study in Lahor, Pakistan 15,711 -
51,239 54,524

. Grants to individuals

Name of grant 2023 2023 2022 2022
Number £ Number £
Junior Travelling Fellowships (JTFs) 21 21,000 22 22,000
Soriano Lecture award 1 4,115 - -
Victor and Clara award 1 4,115 - -
WCN medals and awards 5 10,534 - -
Angela Vicent prize 1 823 - -
29 40,587 22 22,000

Junior Travelling Fellowships comprise travel grants to enable attendance at international conferences.

Page 32

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

10. Auditors' remuneration

The auditors' remuneration amounts to an auditor fee of £5,544 ( 2022 - £5,268 ) , and non audit services of £6,396 (2022 - £6,462).

11. Staff costs and other information

Wages and salaries
Social security costs
Pension costs		 2023
£
175,314
15,406
20,870
211,590		 2022
£
214,469
21,161
20,036
255,666

The average number of persons employed by the Federation during the year was as follows:

2023 2022
No. No.
Administrative staff (full-time) 3 4

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:

2023 2022
No. No.
In the band £70,001 - £80,000 - 2
In the band £80,001 - £90,000
1 -

During the year, contributions made by the Federation to the personal pension plans of higher paid employees totalled £13,343 (2022 - £13,321).

The key management personnel of the Federation comprise the Management Director and Strategy & Programme Director (2022 - same).

The total employee benefits of these 2 (2022 - same) key management personnel were £131,758 (2022 - £182,822), including employer national insurance and pension contribution costs.

Page 33

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

12. Trustees' remuneration and expenses

During the year, no Trustees received any remuneration or other benefits (2022 - £NIL).

During the year ended 31 December 2023, expenses totalling £101,060 were reimbursed or paid directly to 9 Trustees (2022 - £68,321 to 6 Trustees). Trustees and persons co-opted to the board are reimbursed necessarily-incurred expenses, either by reimbursement or by direct payment to a third party. These are included in the appropriate category of resources expended or prepayments. Such reimbursements, relating to travel, accommodation, subsistence and office expenses.

13. Tangible fixed assets

Cost
At 1 January 2023
Additions
At 31 December 2023
Depreciation
At 1 January 2023
Charge for the year
At 31 December 2023
Net book value
At 31 December 2023
At 31 December 2022		 Fixtures,
fittings and
equipment
£
21,518
5,705
27,223
14,080
2,832
16,912
10,311
7,438

The Federation's fixtures, fittings and equipment are used for management and administration purposes.

Page 34

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023
14.
Fixed asset investments
Cost or valuation
At 1 January 2023
Revaluations
At 31 December 2023
Net book value
At 31 December 2023
At 31 December 2022
Historical cost		 Listed
investments
£
3,030,915
138,669
3,169,584
3,169,584
3,030,915
2,822,002

Page 35

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

14. Fixed asset investments (continued)

Investments at market value comprise:

2023 2022 £ £ Listed investments 3,169,584 3,030,915 All the fixed asset investments are held in the UK.

Material investments

Dimensional Funds ICVC
- Emerging Markets Core Equity Fund Income Shares
Dimensional Funds ICVC
- Global Short Bond Fund Income Shares
Dimensional Funds ICVC
- UK Smaller Companies Fund Income Shares
Dimensional Funds ICVC - UK Value Fund Income Shares
Dimensional Funds Plc
- Global Short Term Investment Grade Fixed GBP Income Shares
Dimensional Funds Plc
- Global Sustainable Core Equity GBP Income Shares
Dimensional Funds Plc
- Global Targeted Value Income Shares
iShares UK Equity Index D		 2023
£
178,580
905,360
149,688
183,316
911,220
474,447
94,573
272,400
3,169,584		 2022
£
171,639
885,368
143,009
175,970
889,082
416,467
87,701
260,959
3,030,195

15. Debtors

Due within one year
Other debtors
Prepayments and accrued income		 2023
£
971,271
208,496
1,179,767		 2022
£
1,022,841
215,867
1,238,708

Page 36

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

15. Debtors (continued)

As at 31 December 2023, £932,233 (2022 - £1,022,841) of other debtors is represented by uninvested cash or cash held in short term fixed interest deposits held by the charity's investment managers.

16. Creditors: Amounts falling due within one year

Other taxation and social security
Other creditors
Accruals and deferred income		 2023
£
1,206
483,142
16,131
500,479		 2022
£
5,469
70,196
18,442
94,107

17. Financial instruments

2023 2022
£ £
Financial assets
Financial assets measured at fair value through income and expenditure 1,592,034 1,338,438

Financial assets measured at fair value through income and expenditure comprise cash at bank and in hand.

Page 37

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

18. Statement of funds

Statement of funds - current year

Designated funds
Prof. Theodore Munsat fund
General funds
General Funds
Total Unrestricted funds
Restricted funds
Research Comittee fund
Victor and Clara Soriano fund
Continuing Medical Education
(CME) fund
Latin America Initiative fund
Angela Vincent fund
Total of funds		 Balance at 1
January
2023
£
2,139
5,257,348
5,259,487
37,144
197,086
3,566
20,870
3,239
261,905
5,521,392		 Income
£
811
721,345
722,156
-
-
-
-
-
-
722,156		 Expenditure
£
(2,469)
(923,593)
(926,062)
-
(4,115)
-
-
(823)
(4,938)
(931,000)		 Gains/
(Losses)
£
-
138,669
138,669
-
-
-
-
-
-
138,669		 Balance at
31
December
2023
£
481
5,193,769
5,194,250
37,144
192,971
3,566
20,870
2,416
256,967
5,451,217

Page 38

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

18. Statement of funds (continued)

Statement of funds - prior year

Designated funds
Africa Initiative fund
Prof. Theodore Munsat fund
General funds
General Funds
Total Unrestricted funds
Restricted funds
Research Comittee fund
Victor and Clara Soriano fund
Continuing Medical Education
(CME) fund
Latin America Initiative fund
Angela Vincent fund
Total of funds		 Balance at
1 January
2022
£
33,676
2,116
35,792
5,549,677
5,585,469
36,740
194,941
3,527
20,643
3,204
259,055
5,844,524		 Income
£
1,198
23
1,221
615,626
616,847
404
2,145
39
227
35
2,850
619,697		 Expenditure
£
(34,874)
-
(34,874)
(657,607)
(692,481)
-
-
-
-
-
-
(692,481)		 Gains/
(Losses)
£
-
-
-
(250,348)
(250,348)
-
-
-
-
-
-
(250,348)		 Balance at
31
December
2022
£
-
2,139
2,139
5,257,348
5,259,487
37,144
197,086
3,566
20,870
3,239
261,905
5,521,392

Page 39

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

18. Statement of funds (continued)

Research Committee fund

This is available to support the activities of the Research Committee and its constituent research groups.

Victor and Clara Soriano fund

This represents gifts received from Victor and Clara Soriano in support of the Victor and Clara Soriano Lecture, which also takes place during each world congress, plus interest thereon and net of appropriate expenditure. The lecturer receives a bronze plaque and an honorarium of US$5,000 plus business class airfare.

Continuing Medical Education (CME) fund

This comprises a number of separate funds each set up to receive income for, and to meet expenditure in respect of, continuing education in neurology in a particular part of the world.

Latin American Initiative fund

Represents seed money held for the Pan-American Federation until they establish its legal status. The transfer in of £12,160 from unrestricted funds was approved by the trustees during the year ended 31 December 2016.

Angela Vincent fund

To support the training and education of young neurologists especially in low and low-middle income countries.

Page 40

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

19. Summary of funds

Summary of funds - current year

Designated funds
General funds
Restricted funds		 Balance at 1
January
2023
£
2,139
5,257,348
261,905
5,521,392
Balance at
1 January
2022
£
35,792
5,549,677
259,055
5,844,524		 Income
£
811
721,345
-
722,156
Income
£
1,221
615,626
2,850
619,697		 Expenditure
£
(2,469)
(923,593)
(4,938)
(931,000)
Expenditure
£
(34,874)
(657,607)
-
(692,481)		 Gains/
(Losses)
£
-
138,669
-
138,669
Gains/
(Losses)
£
-
(250,348)
-
(250,348)		 Balance at
31
December
2023
£
481
5,193,769
256,967
5,451,217
Balance at
31
December
2022
£
2,139
5,257,348
261,905
Summary of funds - prior year
Designated funds
General funds
Restricted funds
5,521,392

20. Analysis of net assets between funds

Analysis of net assets between funds - current year

Unrestricted
funds
2023
£
Tangible fixed assets
10,311
Fixed asset investments
3,169,584
Current assets
2,514,834
Creditors due within one year
(500,479)
Total
5,194,250		 Restricted
funds
2023
£
-
-
256,967
-
256,967		 Total
funds
2023
£
10,311
3,169,584
2,771,801
(500,479)
5,451,217

Page 41

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

20. Analysis of net assets between funds (continued)

Analysis of net assets between funds - prior year

Tangible fixed assets
Fixed asset investments
Current assets
Creditors due within one year
Total		 Unrestricted
funds
2022
£
7,438
3,028,065
2,318,091
(94,107)
5,259,487		 Restricted
funds
2022
£
-
2,850
259,055
-
261,905		 Total
funds
2022
£
7,438
3,030,915
2,577,146
(94,107)
5,521,392

21. Reconciliation of net movement in funds to net cash flow from operating activities

Net expenditure for the year (as per Statement of Financial Activities)
Adjustments for:
Depreciation charges
Gains/(losses) on investments
Dividends, interests and rents from investments
Decrease in stocks
Decrease in debtors
Increase/(Decrease) in creditors
Net cash provided by operating activities
22.
Analysis of cash and cash equivalents
Cash in hand		 2023
£
(70,175)
2,832
(138,669)
(117,240)
-
58,941
406,372
142,061
2023
£
1,592,034		 2022
£
(323,132)
1,687
250,349
(64,299)
1,031
425,241
(12,566)
278,311
2022
£
1,338,438

Page 42

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

23. Analysis of changes in net debt

At 1 At 31
January December
2023 Cash flows 2023
£ £ £
Cash at bank and in hand 1,338,438 253,596 1,592,034

24. Pension commitments

Included within Accruals and deferred income (please see Note 16 Creditors: Amounts falling due within one year) is £nil (2022 - £533) relating to pension contributions payable into defined contribution schemes as at 31 December 2023.

25. Operating lease commitments

At 31 December 2023 the Federation had commitments to make future minimum lease payments under non-cancellable operating leases as follows:

2023 2022
£ £
Amounts payable:
Not later than 1 year 2,760 13,800

The following lease payments have been recognised as an expense in the Statement of Financial Activities:

2023 2022
£ £
Operating lease rentals 33,120 57,528

26. Material incoming resources

The major sources of material incoming resources are corporations, organisations and individuals involved in, or with an active interest in, the medical profession.

Page 43

Docusign Envelope ID: EE27DAD4-5DF8-424C-8262-F9D4E813088A

WORLD FEDERATION OF NEUROLOGY

(A company limited by guarantee and not having a share capital)

NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 DECEMBER 2023

27. Related party transactions

2023 2022
£ £
Donations from trustees - 827

Page 44